U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 279

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
ChrX:123019513-123041031
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Sep 10, 2022)
criteria provided, single submitter
2.
GRCh37:
ChrX:123022556
GRCh38:
ChrX:123888706
XIAPK322RX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Mar 15, 2022)
criteria provided, single submitter
3.
GRCh37:
ChrX:123034500
GRCh38:
ChrX:123900650
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Aug 17, 2022)
criteria provided, single submitter
4.
GRCh37:
ChrX:123025082
GRCh38:
ChrX:123891232
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Oct 13, 2022)
criteria provided, single submitter
5.
GRCh37:
ChrX:123019983
GRCh38:
ChrX:123886133
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Sep 7, 2022)
criteria provided, single submitter
6.
GRCh37:
ChrX:123020155
GRCh38:
ChrX:123886305
XIAPR215CX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Dec 21, 2021)
criteria provided, single submitter
7.
GRCh37:
ChrX:123019773
GRCh38:
ChrX:123885923
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Sep 27, 2022)
criteria provided, single submitter
8.
GRCh37:
ChrX:123040895
GRCh38:
ChrX:123907045
XIAPC453YX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 7, 2022)
criteria provided, single submitter
9.
GRCh37:
ChrX:123019646
GRCh38:
ChrX:123885796
XIAPS45LX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Nov 3, 2022)
criteria provided, single submitter
10.
GRCh37:
ChrX:123040965
GRCh38:
ChrX:123907115
XIAPE476DX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Jun 26, 2022)
criteria provided, single submitter
11.
GRCh37:
ChrX:123019657
GRCh38:
ChrX:123885807
XIAPR49*X-linked lymphoproliferative disease due to XIAP deficiencyPathogenic
(Jun 30, 2022)
criteria provided, single submitter
12.
GRCh37:
ChrX:123026623
GRCh38:
ChrX:123892773
XIAPD367NX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Apr 11, 2022)
criteria provided, single submitter
13.
GRCh37:
ChrX:123019920
GRCh38:
ChrX:123886070
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Mar 30, 2022)
criteria provided, single submitter
14.
GRCh37:
ChrX:123020319
GRCh38:
ChrX:123886469
XIAPI269MX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Jan 4, 2022)
criteria provided, single submitter
15.
GRCh37:
ChrX:123020178
GRCh38:
ChrX:123886328
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(May 13, 2022)
criteria provided, single submitter
16.
GRCh37:
ChrX:123034542
GRCh38:
ChrX:123900692
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Sep 29, 2022)
criteria provided, single submitter
17.
GRCh37:
ChrX:123034365
GRCh38:
ChrX:123900515
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Aug 29, 2022)
criteria provided, single submitter
18.
GRCh37:
ChrX:123025176-123025177
GRCh38:
ChrX:123891326-123891327
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Sep 27, 2022)
criteria provided, single submitter
19.
GRCh37:
ChrX:123025119
GRCh38:
ChrX:123891269
XIAPE337*X-linked lymphoproliferative disease due to XIAP deficiencyPathogenic
(Sep 28, 2022)
criteria provided, single submitter
20.
GRCh37:
ChrX:123034507
GRCh38:
ChrX:123900657
XIAPM422VX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(May 30, 2022)
criteria provided, single submitter
21.
GRCh37:
ChrX:123034329
GRCh38:
ChrX:123900479
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Sep 22, 2022)
criteria provided, single submitter
22.
GRCh37:
ChrX:123019530
GRCh38:
ChrX:123885680
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Sep 9, 2022)
criteria provided, single submitter
23.
GRCh37:
ChrX:123025152
GRCh38:
ChrX:123891302
XIAPL348FX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Oct 17, 2022)
criteria provided, single submitter
24.
GRCh37:
ChrX:123040821
GRCh38:
ChrX:123906971
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Oct 5, 2022)
criteria provided, single submitter
25.
GRCh37:
ChrX:123025099-123025100
GRCh38:
ChrX:123891249-123891250
XIAPL331fsX-linked lymphoproliferative disease due to XIAP deficiencyPathogenic
(Sep 13, 2022)
criteria provided, single submitter
26.
GRCh37:
ChrX:123019839
GRCh38:
ChrX:123885989
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jul 11, 2022)
criteria provided, single submitter
27.
GRCh37:
ChrX:123019950
GRCh38:
ChrX:123886100
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jun 13, 2022)
criteria provided, single submitter
28.
GRCh37:
ChrX:123025089
GRCh38:
ChrX:123891239
XIAPC327SX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
29.
GRCh37:
ChrX:123020250
GRCh38:
ChrX:123886400
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(May 28, 2022)
criteria provided, single submitter
30.
GRCh37:
ChrX:123025125
GRCh38:
ChrX:123891275
XIAPI339VX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 28, 2022)
criteria provided, single submitter
31.
GRCh37:
ChrX:123019680
GRCh38:
ChrX:123885830
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Sep 27, 2022)
criteria provided, single submitter
32.
GRCh37:
ChrX:123019976
GRCh38:
ChrX:123886126
XIAPP155LX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(May 17, 2022)
criteria provided, single submitter
33.
GRCh37:
ChrX:123020256
GRCh38:
ChrX:123886406
XIAPR248SX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
34.
GRCh37:
ChrX:123040966
GRCh38:
ChrX:123907116
XIAPA477TX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Jul 30, 2022)
criteria provided, single submitter
35.
GRCh37:
ChrX:123019692
GRCh38:
ChrX:123885842
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jul 4, 2022)
criteria provided, single submitter
36.
GRCh37:
ChrX:123040837
GRCh38:
ChrX:123906987
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Feb 23, 2022)
criteria provided, single submitter
37.
GRCh37:
ChrX:123019977
GRCh38:
ChrX:123886127
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jan 11, 2022)
criteria provided, single submitter
38.
GRCh37:
ChrX:123019990
GRCh38:
ChrX:123886140
XIAPM160VX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Oct 10, 2022)
criteria provided, single submitter
39.
GRCh37:
ChrX:123040918
GRCh38:
ChrX:123907068
XIAPV461IX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 11, 2022)
criteria provided, single submitter
40.
GRCh37:
ChrX:123020044
GRCh38:
ChrX:123886194
XIAPH178YX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 5, 2022)
criteria provided, single submitter
41.
GRCh37:
ChrX:123014249-123021822
GRCh38:
ChrX:123880399-123887972
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely pathogenic
(Dec 6, 2021)
criteria provided, single submitter
42.
GRCh37:
ChrX:123025176-123025177
GRCh38:
ChrX:123891326-123891327
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Dec 27, 2021)
criteria provided, single submitter
43.
GRCh37:
ChrX:123019795
GRCh38:
ChrX:123885945
XIAPG95SX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jun 11, 2021)
criteria provided, single submitter
44.
GRCh37:
ChrX:123026620
GRCh38:
ChrX:123892770
XIAPI366VX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Jun 13, 2022)
criteria provided, single submitter
45.
GRCh37:
ChrX:123034550
GRCh38:
ChrX:123900700
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Jun 25, 2022)
criteria provided, single submitter
46.
GRCh37:
ChrX:123034329
GRCh38:
ChrX:123900479
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Sep 22, 2022)
criteria provided, single submitter
47.
GRCh37:
ChrX:123034485
GRCh38:
ChrX:123900635
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jul 20, 2022)
criteria provided, single submitter
48.
GRCh37:
ChrX:123034473
GRCh38:
ChrX:123900623
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Oct 16, 2022)
criteria provided, single submitter
49.
GRCh37:
ChrX:123019958
GRCh38:
ChrX:123886108
XIAPI149TX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Mar 15, 2022)
criteria provided, single submitter
50.
GRCh37:
ChrX:123019808
GRCh38:
ChrX:123885958
XIAPE99GX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Jul 12, 2022)
criteria provided, single submitter
51.
GRCh37:
ChrX:123019584
GRCh38:
ChrX:123885734
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jul 14, 2021)
criteria provided, single submitter
52.
GRCh37:
ChrX:123022506
GRCh38:
ChrX:123888656
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Mar 15, 2022)
criteria provided, single submitter
53.
GRCh37:
ChrX:123025185
GRCh38:
ChrX:123891335
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Sep 20, 2022)
criteria provided, single submitter
54.
GRCh37:
ChrX:123034324
GRCh38:
ChrX:123900474
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Oct 24, 2022)
criteria provided, single submitter
55.
GRCh37:
ChrX:123020396-123020397
GRCh38:
ChrX:123886546-123886547
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Oct 20, 2021)
criteria provided, single submitter
56.
GRCh37:
ChrX:123040851
GRCh38:
ChrX:123907001
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Nov 1, 2022)
criteria provided, single submitter
57.
GRCh37:
ChrX:123040974
GRCh38:
ChrX:123907124
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Oct 5, 2022)
criteria provided, single submitter
58.
GRCh37:
ChrX:123019998
GRCh38:
ChrX:123886148
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Sep 14, 2021)
criteria provided, single submitter
59.
GRCh37:
ChrX:123026643
GRCh38:
ChrX:123892793
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Feb 3, 2021)
criteria provided, single submitter
60.
GRCh37:
ChrX:123040818
GRCh38:
ChrX:123906968
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Apr 27, 2021)
criteria provided, single submitter
61.
GRCh37:
ChrX:123025184-123025185
GRCh38:
ChrX:123891334-123891335
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jul 20, 2021)
criteria provided, single submitter
62.
GRCh37:
ChrX:123034560
GRCh38:
ChrX:123900710
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jun 13, 2021)
criteria provided, single submitter
63.
GRCh37:
ChrX:123020061
GRCh38:
ChrX:123886211
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Oct 22, 2021)
criteria provided, single submitter
64.
GRCh37:
ChrX:123020314
GRCh38:
ChrX:123886464
XIAPR268WX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 31, 2022)
criteria provided, single submitter
65.
GRCh37:
ChrX:123034477
GRCh38:
ChrX:123900627
XIAPA412SX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
66.
GRCh37:
ChrX:123040854-123040855
GRCh38:
ChrX:123907004-123907005
XIAPQ440*X-linked lymphoproliferative disease due to XIAP deficiencyLikely pathogenic
(Sep 2, 2021)
criteria provided, single submitter
67.
GRCh37:
ChrX:123040919
GRCh38:
ChrX:123907069
XIAPF462fsX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
68.
GRCh37:
ChrX:123020120-123020122
GRCh38:
ChrX:123886270-123886272
XIAPG205delX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 9, 2021)
criteria provided, single submitter
69.
GRCh37:
ChrX:123020290
GRCh38:
ChrX:123886440
XIAPP260SX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Feb 5, 2022)
criteria provided, single submitter
70.
GRCh37:
ChrX:123025158
GRCh38:
ChrX:123891308
XIAPE350*X-linked lymphoproliferative disease due to XIAP deficiencyPathogenic
(Jun 14, 2021)
criteria provided, single submitter
71.
GRCh37:
ChrX:122318388-123505241
STAG2, THOC2, XIAP, GRIA3, SH2D1Anot provided, X-linked lymphoproliferative disease due to XIAP deficiencyConflicting interpretations of pathogenicity
(Dec 23, 2021)
criteria provided, conflicting interpretations
72.
GRCh37:
ChrX:123022510-123022513
GRCh38:
ChrX:123888660-123888663
XIAPT308fsX-linked lymphoproliferative disease due to XIAP deficiencyPathogenic
(Oct 20, 2021)
criteria provided, single submitter
73.
GRCh37:
ChrX:123022478
GRCh38:
ChrX:123888628
XIAPD296GX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
74.
GRCh37:
ChrX:123040852
GRCh38:
ChrX:123907002
XIAPE439*X-linked lymphoproliferative disease due to XIAP deficiencyPathogenic
(Jan 16, 2022)
criteria provided, single submitter
75.
GRCh37:
ChrX:123019880
GRCh38:
ChrX:123886030
XIAPS123NX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Sep 30, 2022)
criteria provided, single submitter
76.
GRCh37:
ChrX:123019513-123020409
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Feb 2, 2022)
criteria provided, single submitter
77.
GRCh37:
ChrX:123020317
GRCh38:
ChrX:123886467
XIAPI269LX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
78.
GRCh37:
ChrX:123020264-123020265
GRCh38:
ChrX:123886414-123886415
XIAPN252fsX-linked lymphoproliferative disease due to XIAP deficiencyPathogenic
(Sep 20, 2021)
criteria provided, single submitter
79.
GRCh37:
ChrX:123020021
GRCh38:
ChrX:123886171
XIAPF170YX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 14, 2021)
criteria provided, single submitter
80.
GRCh37:
ChrX:123019971
GRCh38:
ChrX:123886121
XIAPI153MX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
81.
GRCh37:
ChrX:123020209
GRCh38:
ChrX:123886359
XIAPR233WX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Sep 24, 2021)
criteria provided, single submitter
82.
GRCh37:
ChrX:123040865
GRCh38:
ChrX:123907015
XIAPR443HX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
83.
GRCh37:
ChrX:123019812
GRCh38:
ChrX:123885962
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jul 19, 2022)
criteria provided, single submitter
84.
GRCh37:
ChrX:123019693
GRCh38:
ChrX:123885843
XIAPV61MX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
85.
GRCh37:
ChrX:123020228
GRCh38:
ChrX:123886378
XIAPS239NX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Nov 26, 2021)
criteria provided, single submitter
86.
GRCh37:
ChrX:123019715
GRCh38:
ChrX:123885865
XIAPA68Vnot provided, X-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
ChrX:123020093
GRCh38:
ChrX:123886243
XIAPI194NX-linked lymphoproliferative disease due to XIAP deficiencyUncertain significance
(Jun 28, 2021)
criteria provided, single submitter
88.
GRCh37:
ChrX:123022464
GRCh38:
ChrX:123888614
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Sep 29, 2022)
criteria provided, single submitter
89.
GRCh37:
ChrX:123040953
GRCh38:
ChrX:123907103
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Sep 12, 2022)
criteria provided, single submitter
90.
GRCh37:
ChrX:123034439
GRCh38:
ChrX:123900589
XIAPI399RX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(May 12, 2022)
criteria provided, single submitter
91.
GRCh37:
ChrX:123034437
GRCh38:
ChrX:123900587
XIAPQ398HX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Jun 26, 2022)
criteria provided, single submitter
92.
GRCh37:
ChrX:123019535
GRCh38:
ChrX:123885685
XIAPG8EX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(May 25, 2022)
criteria provided, single submitter
93.
GRCh37:
ChrX:123026599
GRCh38:
ChrX:123892749
XIAPT359AX-linked lymphoproliferative disease due to XIAP deficiencyConflicting interpretations of pathogenicity
(Feb 5, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
ChrX:123019820
GRCh38:
ChrX:123885970
XIAPT103MX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Nov 1, 2022)
criteria provided, single submitter
95.
GRCh37:
ChrX:123019658
GRCh38:
ChrX:123885808
XIAPR49QX-linked lymphoproliferative disease due to XIAP deficiencyBenign
(Apr 11, 2019)
criteria provided, single submitter
96.
GRCh37:
ChrX:123022479-123022483
GRCh38:
ChrX:123888629-123888633
XIAPK299fsX-linked lymphoproliferative disease due to XIAP deficiency, not providedPathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
ChrX:123034344
GRCh38:
ChrX:123900494
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Aug 3, 2021)
criteria provided, single submitter
98.
GRCh37:
ChrX:123020382
GRCh38:
ChrX:123886532
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Aug 10, 2020)
criteria provided, single submitter
99.
GRCh37:
ChrX:123034392
GRCh38:
ChrX:123900542
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(May 5, 2021)
criteria provided, single submitter
100.
GRCh37:
ChrX:123022465
GRCh38:
ChrX:123888615
XIAPX-linked lymphoproliferative disease due to XIAP deficiencyLikely benign
(Jul 25, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination